Epstein-barr virus BGLF4 kinase retards cellular S-phase progression and induces chromosomal abnormality

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Chang, Yu Hsin ^a   Lee, Chung Pei ^a,b   Su, Mei Tzu ^a   Wang, Jiin Tarng ^a   Chen, Jen Yang ^a,c   Lin, Su Fang ^c   Tsai, Ching Hwa ^a   Hsieh, Min Jei ^c   Takada, Kenzo ^d   Chen, Mei Ru ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 1; DNA; HELICASE; PROTEIN BGLF4; UNCLASSIFIED DRUG; VIRUS PROTEIN; BGLF4 PROTEIN, EPSTEIN BARR VIRUS; BGLF4 PROTEIN, EPSTEIN-BARR VIRUS; E2F1 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; RETINOBLASTOMA PROTEIN; THYMIDINE; TRANSCRIPTION FACTOR E2F1;

ANTIBODY DETECTION; ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL GROWTH; CELL POPULATION; CHROMOSOME ABERRATION; CHROMOSOME CONDENSATION; CHROMOSOME STRUCTURE; DNA REPLICATION; DNA SYNTHESIS; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PLASMID; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SACCHAROMYCES CEREVISIAE; SEQUENCE HOMOLOGY; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL CYCLE G1 PHASE; CELL LINEAGE; CELL PROLIFERATION; DNA DAMAGE; ENZYMOLOGY; GENETICS; GENOMIC INSTABILITY; METABOLISM; MICRONUCLEUS; MUTATION; PHOSPHORYLATION; TEMPERATURE; TUMOR CELL LINE;

HUMAN HERPESVIRUS 4; MAMMALIA;

CDC2 PROTEIN KINASE; CELL LINE, TUMOR; CELL LINEAGE; CELL PROLIFERATION; CHROMOSOME ABERRATIONS; DNA; DNA DAMAGE; E2F1 TRANSCRIPTION FACTOR; G1 PHASE; GENOMIC INSTABILITY; HERPESVIRUS 4, HUMAN; HUMANS; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MODELS, BIOLOGICAL; MUTATION; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RETINOBLASTOMA PROTEIN; S PHASE; SACCHAROMYCES CEREVISIAE; TEMPERATURE; THYMIDINE; VIRAL PROTEINS;

EID: 84863111539     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039217     Document Type: Article

References (50)

1. Young LS, Rickinson AB, (2004) Epstein-Barr virus: 40 years on. Nat Rev Cancer 4: 757-768.
2. Mauser A, Holley-Guthrie E, Zanation A, Yarborough W, Kaufmann W, et al. (2002) The Epstein-Barr virus immediate-early protein BZLF1 induces expression of E2F-1 and other proteins involved in cell cycle progression in primary keratinocytes and gastric carcinoma cells. J Virol 76: 12543-12552.
3. Kudoh A, Daikoku T, Sugaya Y, Isomura H, Fujita M, et al. (2004) Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication. J Virol 78: 104-115.
4. Kudoh A, Fujita M, Kiyono T, Kuzushima K, Sugaya Y, et al. (2003) Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication. J Virol 77: 851-861.
5. Kudoh A, Fujita M, Zhang L, Shirata N, Daikoku T, et al. (2005) Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment. J Biol Chem 280: 8156-8163.
6. Fang CY, Lee CH, Wu CC, Chang YT, Yu SL, et al. (2009) Recurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cells. Int J Cancer 124: 2016-2025.
7. Kawaguchi Y, Kato K, Tanaka M, Kanamori M, Nishiyama Y, et al. (2003) Conserved protein kinases encoded by herpesviruses and cellular protein kinase cdc2 target the same phosphorylation site in eukaryotic elongation factor 1delta. J Virol 77: 2359-2368.
8. Gershburg E, Pagano JS, (2008) Conserved herpesvirus protein kinases. Biochim Biophys Acta 1784: 203-212.
9. Kato K, Kawaguchi Y, Tanaka M, Igarashi M, Yokoyama A, et al. (2001) Epstein-Barr virus-encoded protein kinase BGLF4 mediates hyperphosphorylation of cellular elongation factor 1delta (EF-1delta): EF-1delta is universally modified by conserved protein kinases of herpesviruses in mammalian cells. J Gen Virol 82: 1457-1463.
10. Iwahori S, Murata T, Kudoh A, Sato Y, Nakayama S, et al. (2009) Phosphorylation of p27Kip1 by Epstein-Barr virus protein kinase induces its degradation through SCFSkp2 ubiquitin ligase actions during viral lytic replication. J Biol Chem 284: 18923-18931.
11. Kudoh A, Daikoku T, Ishimi Y, Kawaguchi Y, Shirata N, et al. (2006) Phosphorylation of MCM4 at sites inactivating DNA helicase activity of the MCM4-MCM6-MCM7 complex during Epstein-Barr virus productive replication. J Virol 80: 10064-10072.
12. Lee CP, Chen JY, Wang JT, Kimura K, Takemoto A, et al. (2007) Epstein-Barr virus BGLF4 kinase induces premature chromosome condensation through activation of condensin and topoisomerase II. J Virol 81: 5166-5180.
13. Lee CP, Huang YH, Lin SF, Chang Y, Chang YH, et al. (2008) Epstein-Barr virus BGLF4 kinase induces disassembly of the nuclear lamina to facilitate virion production. J Virol 82: 11913-11926.
14. Zhu J, Liao G, Shan L, Zhang J, Chen MR, et al. (2009) Protein array identification of substrates of the Epstein-Barr virus protein kinase BGLF4. J Virol 83: 5219-5231.
15. Kuny CV, Chinchilla K, Culbertson MR, Kalejta RF, (2010) Cyclin-dependent kinase-like function is shared by the beta- and gamma- subset of the conserved herpesvirus protein kinases. PLoS Pathog 6.
16. Tarakanova VL, Leung-Pineda V, Hwang S, Yang CW, Matatall K, et al. (2007) Gamma-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication. Cell Host Microbe 1: 275-286.
17. Li R, Zhu J, Xie Z, Liao G, Liu J, et al. (2011) Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. Cell Host Microbe 10: 390-400.
18. Chang Y, Tung CH, Huang YT, Lu J, Chen JY, et al. (1999) Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes. J Virol 73: 8857-8866.
19. Delecluse HJ, Hilsendegen T, Pich D, Zeidler R, Hammerschmidt W, (1998) Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci U S A 95: 8245-8250.
20. Bloom J, Cross FR, (2007) Multiple levels of cyclin specificity in cell-cycle control. Nat Rev Mol Cell Biol 8: 149-160.
21. Lorincz AT, Reed SI, (1986) Sequence analysis of temperature-sensitive mutations in the Saccharomyces cerevisiae gene CDC28. Mol Cell Biol 6: 4099-4103.
22. Chen KC, Csikasz-Nagy A, Gyorffy B, Val J, Novak B, et al. (2000) Kinetic analysis of a molecular model of the budding yeast cell cycle. Mol Biol Cell 11: 369-391.
23. Kanda T, Sullivan KF, Wahl GM, (1998) Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells. Curr Biol 8: 377-385.
24. Heddle JA, Cimino MC, Hayashi M, Romagna F, Shelby MD, et al. (1991) Micronuclei as an index of cytogenetic damage: past, present, and future. Environ Mol Mutagen 18: 277-291.
25. El Achkar E, Gerbault-Seureau M, Muleris M, Dutrillaux B, Debatisse M, (2005) Premature condensation induces breaks at the interface of early and late replicating chromosome bands bearing common fragile sites. Proc Natl Acad Sci U S A 102: 18069-18074.
26. Goodrich DW, Wang NP, Qian YW, Lee EY, Lee WH, (1991) The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67: 293-302.
27. Knudsen ES, Buckmaster C, Chen TT, Feramisco JR, Wang JY, (1998) Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression. Genes Dev 12: 2278-2292.
28. Chen PL, Scully P, Shew JY, Wang JY, Lee WH, (1989) Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58: 1193-1198.
29. Lundberg AS, Weinberg RA, (1998) Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 18: 753-761.
30. Hiebert SW, Chellappan SP, Horowitz JM, Nevins JR, (1992) The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev 6: 177-185.
31. Kitagawa M, Higashi H, Jung HK, Suzuki-Takahashi I, Ikeda M, et al. (1996) The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J 15: 7060-7069.
32. Knudsen ES, Wang JY, (1997) Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol Cell Biol 17: 5771-5783.
33. Inoue Y, Kitagawa M, Taya Y, (2007) Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage. EMBO J 26: 2083-2093.
34. Hume AJ, Finkel JS, Kamil JP, Coen DM, Culbertson MR, et al. (2008) Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science 320: 797-799.
35. Liao CC, Tsai CY, Chang WC, Lee WH, Wang JM, (2010) RB.E2F1 complex mediates DNA damage responses through transcriptional regulation of ZBRK1. J Biol Chem 285: 33134-33143.
36. Coudreuse D, Nurse P, (2010) Driving the cell cycle with a minimal CDK control network. Nature 468: 1074-1079.
37. Yang PW, Chang SS, Tsai CH, Chao YH, Chen MR, (2008) Effect of phosphorylation on the transactivation activity of Epstein-Barr virus BMRF1, a major target of the viral BGLF4 kinase. J Gen Virol 89: 884-895.
38. Malumbres M, Barbacid M, (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9: 153-166.
39. Negrini S, Gorgoulis VG, Halazonetis TD, (2010) Genomic instability-an evolving hallmark of cancer. Nat Rev Mol Cell Biol 11: 220-228.
40. McClendon H, Buckner EB, (2007) Distressing situations in the intensive care unit: a descriptive study of nurses' responses. Dimens Crit Care Nurs 26: 199-206.
41. Super HJ, McCabe NR, Thirman MJ, Larson RA, Le Beau MM, et al. (1993) Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood 82: 3705-3711.
42. Aplan PD, Chervinsky DS, Stanulla M, Burhans WC, (1996) Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors. Blood 87: 2649-2658.
43. Depowski PL, Rosenthal SI, Brien TP, Stylos S, Johnson RL, et al. (2000) Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables. Mod Pathol 13: 542-547.
44. Mekhail K, Moazed D, (2010) The nuclear envelope in genome organization, expression and stability. Nat Rev Mol Cell Biol 11: 317-328.
45. Wang JT, Yang PW, Lee CP, Han CH, Tsai CH, et al. (2005) Detection of Epstein-Barr virus BGLF4 protein kinase in virus replication compartments and virus particles. J Gen Virol 86: 3215-3225.
46. Chen PL, Riley DJ, Chen Y, Lee WH, (1996) Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev 10: 2794-2804.
47. Ou YH, Chung PH, Hsu FF, Sun TP, Chang WY, et al. (2007) The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1. EMBO J 26: 3968-3980.
48. Lin CT, Wong CI, Chan WY, Tzung KW, Ho JK, et al. (1990) Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lab Invest 62: 713-724.
49. Maruo S, Yang L, Takada K, (2001) Roles of Epstein-Barr virus glycoproteins gp350 and gp25 in the infection of human epithelial cells. J Gen Virol 82: 2373-2383.
50. Tsai CH, Liu MT, Chen MR, Lu J, Yang HL, et al. (1997) Characterization of Monoclonal Antibodies to the Zta and DNase Proteins of Epstein-Barr Virus. J Biomed Sci 4: 69-77.